Endocrine Abstracts

IntroductionMedical immunosuppressive treatment of Graves’ orbitopathy (GO) is advised for patents with moderate-severe disease. Steroids represent the mainstay of therapy, as they possess anti-inflammatory activity, but about 20 – 30% of patients are unresponsive and up to 20% of patients may relapse. Immunosuppressive therapeutics alternative to corticosteroids are those targeting the different antigens involved in the pathogenic reactions of...